Accessibility settings

This paper is in the following e-collection/theme issue:

Economic Evaluations of mHealth Programs and Infrastructures (56) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1839) Wearable Devices and Sensors (1240) mHealth for Telemedicine and Homecare (578)

Published on in Vol 14 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/72242, first published .
Efficacy and Safety of a Telemedicine System in Patients With Gestational Diabetes Mellitus (TELEGLAM): Single-Center, 2-Arm, Randomized, Open-Label, Parallel-Group Study

Efficacy and Safety of a Telemedicine System in Patients With Gestational Diabetes Mellitus (TELEGLAM): Single-Center, 2-Arm, Randomized, Open-Label, Parallel-Group Study

Efficacy and Safety of a Telemedicine System in Patients With Gestational Diabetes Mellitus (TELEGLAM): Single-Center, 2-Arm, Randomized, Open-Label, Parallel-Group Study

Authors of this article:

Kazuki Aoyama1 Author Orcid Image ;   Yuya Nakajima2 Author Orcid Image ;   Shu Meguro1 Author Orcid Image ;   Yasunori Sato3 Author Orcid Image ;   Rei Goto4 Author Orcid Image ;   Mariko Hida5 Author Orcid Image ;   Takeshi Arimitsu5 Author Orcid Image ;   Yoshifumi Kasuga6 Author Orcid Image ;   Mamoru Tanaka6 Author Orcid Image ;   Hiroshi Itoh2 Author Orcid Image ;   Kaori Hayashi1 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.